ITOS
iTeos Therapeutics
ITOS
ITOS
Delisted
ITOS was delisted on the 28th of August, 2025.
152 hedge funds and large institutions have $768M invested in iTeos Therapeutics in 2022 Q2 according to their latest regulatory filings, with 28 funds opening new positions, 72 increasing their positions, 32 reducing their positions, and 31 closing their positions.
New
Increased
Maintained
Reduced
Closed
Holders
152
Holders Change
-7
Holders Change %
-4.4%
% of All Funds
2.57%
Holding in Top 10
3
Holding in Top 10 Change
-2
Holding in Top 10 Change %
-40%
% of All Funds
0.05%
New
28
Increased
72
Reduced
32
Closed
31
Calls
$5.65M
Puts
$1.48M
Net Calls
+$4.17M
Net Calls Change
+$5.9M
Top Buyers
| 1 |
State Street
Boston,
Massachusetts
|
+$15.8M |
| 2 |
PHS
PFM Health Sciences
San Francisco,
California
|
+$11.1M |
| 3 |
BI
BVF Inc
San Francisco,
California
|
+$10.9M |
| 4 |
BlackRock
New York
|
+$8.03M |
| 5 |
Invesco
Atlanta,
Georgia
|
+$7.86M |
Top Sellers
| 1 |
BC
Boxer Capital
San Diego,
California
|
-$21.4M |
| 2 |
RI
RTW Investments
New York
|
-$15.7M |
| 3 |
OCA
Octagon Capital Advisors
New York
|
-$14.5M |
| 4 |
Pacer Advisors
Malvern,
Pennsylvania
|
-$14.3M |
| 5 |
AllianceBernstein
Nashville,
Tennessee
|
-$10M |
